BridgeBio Pharma, Inc. Common Stock (BBIO)

BridgeBio Pharma's stock $BBIO surges to a 52-week and all-time high following positive Phase [--] results for BBP-418, with analysts raising price targets to $100.

About BridgeBio Pharma, Inc. Common Stock

BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded stock in the healthcare sector focused on developing innovative medicines.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance is up 146.75% from the previous [--] months.
BridgeBio Pharma, Inc. Common Stock (BBIO) creators is up 113.75% from the previous week.
BridgeBio Pharma, Inc. Common Stock (BBIO) engagements is up 184.62% from the previous week.
BridgeBio Pharma, Inc. Common Stock (BBIO) mentions is up 137.31% from the previous week.
BridgeBio Pharma, Inc. Common Stock (BBIO) posts created is up 314.29% from the previous week.
BridgeBio Pharma, Inc. Common Stock Price hit a 52-Week high of $88 for the hour
BridgeBio Pharma, Inc. Common Stock Price hit an all time of $88 for the hour

Price: $75.30

Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week and all-time high, driven by highly positive Phase [--] results for BBP-418 and strong market performance, despite some concerns about European patent issues and company debt.

24-Hour: -2.97% 7-Day: 8.06% 30-Day: -1.32%

1-Year High: $79.90 on 2026-01-22
1-Year Low: $30.10 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #669 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] [---]
[--] Year: [---] +234
1-Year High: [-----] on 2026-01-26
1-Year Low: [--] on 2025-05-17

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +15
[--] Months: [--] +11
[--] Year: [--] +12
1-Year High: [--] on 2025-12-08
1-Year Low: [--] on 2025-12-25

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +185%
[--] Month: [---------] +88%
[--] Months: [---------] -7.70%
[--] Year: [----------] +7.90%
1-Year High: [-------] on 2025-02-20
1-Year Low: [-----] on 2025-12-07

Engagements by network (24h): X: [------] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +137%
[--] Month: [-----] +63%
[--] Months: [-----] +1.80%
[--] Year: [-----] +46%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): X: [---] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last [--] hours which is down 13% from [---] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +114%
[--] Month: [---] +33%
[--] Months: [-----] -13%
[--] Year: [-----] +90%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-12

The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@semodough	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[-----]
@PersimmonTI	[--]	[------]	[--]	[-----]
@biomednexus	[--]	[--]	[--]	[---]
@Biotech2k1	[--]	[------]	[--]	[---]
@Pharmdca	[--]	[-------]	[--]	[---]
@thenewceo_	[--]	[---]	[--]	[---]
@augurbio	[--]	[---]	[--]	[---]
@DmitryKovalchuk	[--]	[-----]	[--]	[--]
@DwightS2025	[--]	[---]	[--]	[--]

Sentiment: 82%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 82%
Daily Average: 77%
[--] Week: 80% -1%
[--] Month: 77% +15%
[--] Months: 77% +8%
[--] Year: 77% +13%
1-Year High: 96% on 2025-10-06
1-Year Low: 40% on 2025-05-28

Most Supportive Themes:

Positive Phase [--] Results for BBP-418: (50%) BridgeBio Pharma's drug for a muscle disorder, BBP-418, met its goals in a late-stage trial, leading to positive sentiment and stock price surges.
Strong Market Performance and Increased Market Cap: (30%) The stock's price action is also attributed to the overall strong market performance and a significant increase in market capitalization.

Most Critical Themes:

FDA Hold on Intellia Therapeutics: (10%) While not directly about BBIO, news of an FDA hold on a competitor like Intellia Therapeutics can impact overall biotech sentiment and investor focus.
Debt and Cash Burn: (10%) Some posts mention the company's debt and cash burn, which could be a point of concern for investors despite positive trial results.

Social Dominance: 0.026%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.026%
Daily Average: 0.022%
[--] Week: 0.027% +0.011%
[--] Month: 0.038% +0.021%
[--] Months: 0.038% +0.0033%
[--] Year: 0.038% -0.0011%
1-Year High: 0.068% on 2025-06-28
1-Year Low: 0.0058% on 2025-10-12

Market Dominance: 0.016%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.016%
Daily Average: 0%
1-Year High: 0.018% on 2026-01-02
1-Year Low: 0.00849% on 2025-05-28

Market Cap: $14,419,930,847

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $14,419,930,847
Daily Average: $9,908,483,901
[--] Week: $14,419,930,847 +4.50%
[--] Month: $14,419,930,847 -1.30%
[--] Months: $14,419,930,847 +54%
[--] Year: $14,419,930,847 +117%
1-Year High: $15,312,912,611 on 2026-01-22
1-Year Low: $5,732,285,188 on 2025-04-08

Top BridgeBio Pharma, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"2025 Q4 13F ( ) BDC Belden FDP Fresh Del Monte Produce ACLX Arcellx CAR-T CVLT Commvault Systems BBIO BridgeBio Pharma PTGX Protagonist Therapeutics KURA Kura Oncology DYN Dyne Therapeutics POWW Ammo Inc. CFLT Confluent WDC Western Digital FOX Fox Corporation BCPC Balchem SNX TD SYNNEX IT MIRM Mirum Pharmaceuticals ONEV (ETF) SPDR Russell [----] Momentum ETF ETF HIG The Hartford Insurance Group https://twitter.com/i/web/status/2023327406895817108 https://twitter.com/i/web/status/2023327406895817108"
X Link @fourseasonfan 2026-02-16T09:23Z [----] followers, [----] engagements

"Pharma Stocks Based on Pattern Recognition: Returns up to 178.82% in [--] Year $dmac $pgen $bbio $orgo $smmt $ptgx $bpmc $meip $natr $cocp #stocks #stockmarket #stocktrading #investing https://iknowfirst.com/pharma-stocks-based-on-pattern-recognition-returns-up-to-178-82-in-1-year https://iknowfirst.com/pharma-stocks-based-on-pattern-recognition-returns-up-to-178-82-in-1-year"
X Link @yaron_gol 2026-02-16T02:00Z [----] followers, [---] engagements

"$BBIO at the risk of waxing grandiloquent myself: Im proud to be a part-owner of $BBIO a david whos had to overcome multiple Goliaths. The entrenched institutional darlings in ATTR-CM $ALNY who for a while could do no wrong. (and $PFE menacing) And now those same counterparts in Achondroplasia $ASND $BMRN. acoramidis survived its odyssey and thrives infigratinib will as well: https://twitter.com/i/web/status/2023088061261709411 https://twitter.com/i/web/status/2023088061261709411"
X Link @PersimmonTI 2026-02-15T17:32Z 10.9K followers, [----] engagements

"$BBIO [--] drug generating revenue by [----] Great pipeline will support revenue generation for years $BBIO LR Model first year [----] all [--] drugs launched [---] Billion in revenue &EPS over [--] bucks $BBIO LR Model first year [----] all [--] drugs launched [---] Billion in revenue &EPS over [--] bucks"
X Link @Andre_AGTC 2026-02-15T15:08Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing